📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
22
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
16%
💰 Capital Raise
18%
• Active ATM program with $175M remaining capacity
🔄 Reverse Split
15%
• 52-week low $0.98 has breached $1
📉 Score Deterioration
15%
• Score climbed 6 points (worsening)
💹 Market Data
Market Cap$748.99M
Shares Outstanding345.15M
Float269.64M
Cash$266.89M
Debt$81.05M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.0% shares (2025Q4 vs prior)
169 institutional holders · 164.62M shares
#1
Pfizer Inc
22.03M shares
#2
TPG GP A, LLC
18.72M shares
#3
BlackRock, Inc.
17.68M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest42.28M
Days to Cover6.4
% of Float15.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2020
424B5
ATM
Apr 15, 2026
8-K
8K EVENT
Apr 15, 2026
424B5
ATM
Apr 13, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ALLO
📊 ALLO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ALLO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.